IP Library Granted Patent US 8,119,830
Granted Patent B2
US 8,119,830 · App. 12/722,185 · Granted Feb 21, 2012

Dual function UV-absorbers for ophthalmic lens materials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,119,830
App. No.
12/722,185
Granted
Feb 21, 2012
Kind
B2
Abstract

Disclosed are UV absorbers that contain a labile functional group capable of initiating free radical polymerization.

Claims (8)

1. A dual function UV absorber of the formula:

where Y=nothing or O; R=a benzotriazole or benzophenone UV absorber; R′=a benzotriazole or benzophenone UV absorber; —(CH 2 ) n H (n=1-18); —CH(CH 3 )CH 3 ; —C(CH 3 ) 3 ; —C 6 H 5 ; —CH(CH 3 )CH 2 CH 3 ; —C(CH 3 ) 2 CH 2 C(CH 3 ) 3 ; —C(CH 3 ) 2 (CH 2 ) 4 H; —C(CH 2 CH 3 ) 2 (CH 2 ) 4 H; —C(CH 3 ) 2 (CH 2 ) 5 H; —C(CH 2 CH 3 ) 2 (CH 2 ) 5 H; —C(CH 3 ) 2 (CH 2 ) 6 H; —C(CH 2 CH 3 ) 2 (CH 2 ) 6 H; —CH 2 CH(CH 2 CH 3 )(CH 2 ) 4 H; or

2. A dual function UV absorber of the formula:

where R=a benzotriazole or benzophenone UV absorber; R′=H; a benzotriazole or benzophenone UV absorber; (CH 2 ) n H (n=1-18); CH(CH 3 )CH 3 ; C(CH 3 ) 3 ; CH(CH 3 )CH 2 CH 3 ; C(CH 3 ) 2 CH 2 C(CH 3 ) 3 ; C(CH 3 ) 2 (CH 2 ) 4 H; C(CH 2 CH 3 ) 2 (CH 2 ) 4 H; C(CH 3 ) 2 (CH 2 ) 5 H; C(CH 2 CH 3 ) 2 (CH 2 ) 5 H; C(CH 3 ) 2 (CH 2 ) 6 H; C(CH 2 CH 3 ) 2 (CH 2 ) 6 H; CH 2 CH(CH 2 CH 3 )(CH 2 ) 4 H; or C(CH 3 ) 2 C 6 H 5 .

3. An ophthalmic lens material comprising a dual function UV absorber of claim 1 .

4. The ophthalmic lens material of claim 3 wherein the dual function UV absorber is present in the ophthalmic lens material in an amount of 1-5% (w/w).

5. An ophthalmic lens material comprising a dual function UV absorber of claim 2 .

6. The ophthalmic lens material of claim 5 wherein the dual function UV absorber is present in the ophthalmic lens material in an amount of 1-5% (w/w).

Assignments (2)
CONFIRMATORY DEED OF ASSIGNMENT EFFECTIVE APRIL 8, 2019 Recorded Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
MERGER Recorded May 31, 2011
From: ALCON, INC.
To: NOVARTIS AG
Reel/Frame 026376/0076 →